CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Revenue
Housing	$ 268,582	$ (6,553)
Commercial rental	0	0
Tissue array products	514,593	552,811
Total revenue	783,175	546,258
Cost of Sales
Housing	220,980	58,930
Commercial rental - related party	65,846	64,272
Tissue array products	329,089	421,499
Total cost of sales	615,915	544,701
Gross Profit	167,260	1,557
Operating Expenses:
Salaries and wages	233,124	182,024
Depreciation and amortization	149,925	148,541
Bad debt expense	330	99,541
(Reversals) Estimates of loss contingencies	(38,025)	37,134
Professional fees	77,408	88,695
Selling and distribution expenses	6,654	17,905
Other general and administrative expenses	169,594	157,737
Total Operating Expenses	599,010	731,577
Loss from Operations	(431,750)	(730,020)
Other Income (Expense)
Net interest income (expense)	(194,592)	5,459
Other expense, net	(28,442)	(14,592)
Total Other Expense, Net	(223,034)	(9,133)
Loss before Income Taxes	(654,784)	(739,153)
Income Tax Expense	856	0
Net Loss	(655,640)	(739,153)
Less: Net loss attributable to the non-controlling interests	(125,840)	(139,392)
Net Loss Attributable To CYBRDI, INC.	(529,800)	(599,761)
Foreign currency translation (loss) gain	(10,362)	252,592
Comprehensive Loss Attributable To CYBRDI, INC.	$ (540,162)	$ (347,169)
Net Loss Per Common Share
Basic and Diluted	$ (0.01)	$ (0.01)
Weighted Average Number of Common Shares Outstanding
Basic and Diluted	120,225,323	85,879,746